[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-468888-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-468888-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","high-satisfaction-post-local-osteo-enhancement-procedure-loep-an-open-label-study-in-patients-with-high-fracture-risk","High Satisfaction Post Local Osteo-enhancement Procedure (LOEP) - An Open Label Study in Patients with High Fracture Risk","","Retrospective, open-label, single-surgeon real-world study evaluating a percutaneous local osteo-enhancement procedure (LOEP) using a resorbable calcium-based AGN1 implant placed in hip bone voids. Adults with osteopenia or osteoporosis received AGN1 LOEP between September 2019 and November 2022, after prior LOEP and informed consent. Fifty hips were treated with follow-up averaging 397 days. DXA showed total hip and femoral neck BMD increases of 25-28%. Radiographs suggested implant resorption and regional bone formation in 25 of 26 evaluable cases, while function and pain scores generally improved and satisfaction remained high (median 87/100).",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/high-satisfaction-post-local-osteo-enhancement-procedure-loep-an-open-label-study-in-patients-with-high-fracture-risk/468888/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/high-satisfaction-post-local-osteo-enhancement-procedure-loep-an-open-label-study-in-patients-with-high-fracture-risk/468888.png","ImageObject",300,407,{"name":42,"@type":43},"iuabcfuw","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-30",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of the study?","Question",{"text":63,"@type":64},"To evaluate the percutaneous LOEP using a resorbable calcium-based AGN1 implant in hip bone voids for individuals with osteopenia or osteoporosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Who participated and how was LOEP administered?",{"text":68,"@type":64},"Adults with osteopenia or osteoporosis were enrolled in a retrospective open-label single-surgeon study; eligible participants previously received LOEP and provided written informed consent. AGN1 LOEP was performed on 50 hips between September 2019 and November 2022.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings on bone density and imaging?",{"text":72,"@type":64},"DXA showed mean increases of 25–28% in total hip and femoral neck BMD from baseline after an average 397-day follow-up. Radiographs at about 311 days indicated AGN1 resorption and regional bone formation in 25 of 26 available radiographs.",{"name":74,"@type":61,"acceptedAnswer":75},"How safe was the procedure and what did participants report?",{"text":76,"@type":64},"Eight adverse events related to the device or procedure were observed (18.6%) and were categorized as mild, mainly involving wound complications or implant leakage. Participants generally reported high satisfaction with LOEP (median 87.0/100).","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},468888,1791071528,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,104,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},"Comic",60,"comic",{"id":105,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},6,"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":55,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},3985747874027,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Research Article  \nHigh Satisfaction Post Local Osteo-enhancement Procedure (LOEP): An Open Label Study in Patients with High Fracture Risk  \na b c  \nJonathan Shaul, PhD , Koen Bulterys, BS , Jo De Schepper, M.D.  \nKeywords: Bone loss, BMD, Hip fractures, bone density, bone quality  \n[https://doi.org/10.60118/001c.155444](https://doi.org/10.60118/001c.155444)  \n\n| Journal of Orthopaedic Experience & Innovation\u003Cbr>Vol. 7, Issue 1, 2026 |\n| --- |\n| Purpose\u003Cbr>To evaluate percutaneous local osteo-enhancement procedure (LOEP) using resorbable calcium-based AGN1 implant in hip bone voids of individuals with osteopenia or osteoporosis.\u003Cbr>Methods\u003Cbr>Retrospective, open-label, single-surgeon study of adults with osteopenia or osteoporosis treated with AGN1 LOEP between September 2019 and November 2022. Eligible participants were previously treated with LOEP, willing to participate, and able to give written informed consent. Evaluations consisted of medical record review including pain and functional assessments, and a participant experience questionnaire. 40 women and 3 men treated for bone voids related to osteoporosis/osteopenia participated, all of whom met ≥1 criteria for high (n = 3) or very high (n = 40) fracture risk based on bone mineral density (BMD) T-scores, fracture history, and fracture risk assessment (FRAX®) scores. LOEP was performed on 50 hips, comprising 36 participants treated unilaterally and 7 bilaterally. Participants had a mean follow-up period of 397 days post-LOEP.\u003Cbr>Results\u003Cbr>DXA indicated mean increases in total hip and femoral neck BMD of 25-28% from baseline after a mean follow-up period of 397 days. Radiographs obtained an average of 311 days post-LOEP indicated AGN1 implant material was in resorption process, with radiographic evidence of regional bone formation in 25 of 26 available radiographs. Function and pain scores numerically improved in most participants after LOEP, and participants generally reported high satisfaction with LOEP (median satisfaction score, 87.0/100) . Eight adverse events related to the device or procedure were observed in a total of 43 participants (18.6%) . These events were categorized as mild and related to wound complications (pain, bruising, seroma) or implant material leakage. Four of the eight events were device related and consisted of discomfort, localized pain, and material leakage. |\n\na Jonathan Shaul is a research and development professional at AgNovos Bioscience, where he advances innovative treatments for improving bone health. He holds a PhD in Bioengineering from Clemson University and has followed a career path from academic research into applied R&D, with a focus on translating engineering and biological science into clinically relevant solutions.  \nConnect with Jonathan Shaul on LinkedIn  \nConflicts of Interest Statement for Jonathan Shaulb Visit Koen Bulterys  \nConflicts of Interest Statement for Koen Bulterys  \nc Dr. Jo De Schepper is an orthopaedic surgeon with a high interest in hip fracture, osteoporosis and osteoporotic care. Dr. Jo De Schepper has given numerous presentations on international and national stages including OTA, DKOU and WCO.  \nVisit Dr. Jo De Schepper  \nConnect with Dr. Jo De Schepper on LinkedIn  \nConflicts of Interest Statement for Dr. Jo De Schepper  \nConclusions  \nThis real-world study supports the safety of, and satisfaction with, AGN1 LOEP for the treatment of local bone loss in the hip associated with osteopenia or osteoporosis. Keywords: Hip fracture, osteo-enhancement, fracture prevention, real world experience, patient satisfaction  \nINTRODUCTION  \nHip fractures are among the most common fragility fractures in patients with osteoporosis (Pasco et al. 2006), and their impact accounts for >40% of the global clinical burden of osteoporosis (Johnell and Kanis 2006) and >70% of the overall costs (Burge et al. 2007) . History of hip fracture is a strong predictor of future hip fractures (Colón-Emeric et al. 2003; Gehlbach et al. ","cbCaicXGVQRKmaBO","https://ap.wps.com/l/cbCaicXGVQRKmaBO","pdf",753566,14,"English","# Purpose\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What was the purpose of the study?\",\"answer\":\"To evaluate the percutaneous LOEP using a resorbable calcium-based AGN1 implant in hip bone voids for individuals with osteopenia or osteoporosis.\"},{\"question\":\"Who participated and how was LOEP administered?\",\"answer\":\"Adults with osteopenia or osteoporosis were enrolled in a retrospective open-label single-surgeon study; eligible participants previously received LOEP and provided written informed consent. AGN1 LOEP was performed on 50 hips between September 2019 and November 2022.\"},{\"question\":\"What were the key findings on bone density and imaging?\",\"answer\":\"DXA showed mean increases of 25–28% in total hip and femoral neck BMD from baseline after an average 397-day follow-up. Radiographs at about 311 days indicated AGN1 resorption and regional bone formation in 25 of 26 available radiographs.\"},{\"question\":\"How safe was the procedure and what did participants report?\",\"answer\":\"Eight adverse events related to the device or procedure were observed (18.6%) and were categorized as mild, mainly involving wound complications or implant leakage. Participants generally reported high satisfaction with LOEP (median 87.0/100).\"}]","High Satisfaction Post Local Osteo-enhancement Procedure (LOEP) - An Open Label Study in Patients with High Fracture Risk | PDF",1790774814,35,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/59bda1b4be7e878f88554a54e31688da.webp",983,1390,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/2b1ef74b6b99442bcb3e1cffc6954526.webp",982,1388,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/2ccbd4b8c1755830a2c5f9704dd8833a.webp",981,1387,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/709e4af1fb3a4d5ee134bc2088a140fd.webp",980,1385]